Senna
NDC Package 45865-971-30
Package Information
Senna is take preferably at bedtime or as directed by a doctorif you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage) or decrease does until you are comfortableAgestarting dosagemaximum dosageadults children 12 years and over2 tablets once a day4 tablets twice a daychildren 6 to under 12 years1 tablet once a day2 tabelts twice a daychildren 2 to under 6 years1/2 tablet once a day1 tablet twice a daychildren under 2 yearsask a doctorask a doctor. Marketed by Medsource Pharmaceuticals, this product is identified by NDC 45865-971 and is authorized under FDA application part334.
Identification & Billing
- RxCUI: 312935 - sennosides 8.6 MG Oral Tablet
- RxCUI: 312935 - sennosides, USP 8.6 MG Oral Tablet
- RxCUI: 312935 - sennosides A and B 8.6 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 45865 - Medsource Pharmaceuticals
- 45865-971 - Senna
- 45865-971-30 - 30 TABLET in 1 BOTTLE, PLASTIC
- 45865-971 - Senna
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 45865-971-30 identifies a specific commercial package of 30 tablet in 1 bottle, plastic of Senna, labeled by Medsource Pharmaceuticals. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Medsource Pharmaceuticals on August 01, 2018. The current certification is valid through December 31, 2024.
How is this Medsource Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 45865097130. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.